FABP4 as a therapeutic host target controlling SARS-CoV-2 infection | EMBO Molecular Medicine

Springer Nature Link·Apr 14

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is being conducted on the therapeutic potential of targeting host factors to control SARS-CoV-2 infection. The protein FABP4 has been identified as a possible target, although its role in other infections is also being studied. The search for effective treatments is exploring various approaches, including bioinformatics analysis and immunological perspectives.

Full coverage

FABP4-dependent fatty acid oxidation-fueled mitochondrial ROS induces the mobilization of cellular iron and facilitates Trypanosoma cruzi proliferation in murine adipocytes

ASM Journals·Sep 8

Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection

Nature·Sep 1

Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis

Frontiers·Nov 3

Infection and pathogenesis of SARS-CoV2: an immunological perspective

Chemistry World·Feb 19